Main > ONCOLOGY (**) > Mastocytosis (PreCancerous) *** > Treatment > USA. B. Tyrosine Kinase Inhibitor

---

USA. B. Tyrosine Kinase Inhibitor's subsections
(*) EU CE Mark Date: 2022. 03.25
(*) USA Approval Date: 2021. 06.16.
Company
Generic Name: Avapritinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2021. 06.15.
RTM
RTM Web-Site

USA. B. Tyrosine Kinase Inhibitor's products
This section has no products